AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Down 54.5% in April

Posted by Brenda Bartman on May 16th, 2026

AB Corporate Bond ETF (NASDAQ:EYEG – Get Free Report) was the target of a large decline in short interest in the month of April. As of April 30th, there was short interest totaling 250 shares, a decline of 54.5% from the April 15th total of 549 shares. Based on an average daily volume of 99 shares, the days-to-cover ratio is presently 2.5 days. Approximately 0.0% of the shares of the company are short sold.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jane Street Group LLC boosted its position in AB Corporate Bond ETF by 166.7% during the 4th quarter. Jane Street Group LLC now owns 15,741 shares of the specialty pharmaceutical company’s stock valued at $563,000 after purchasing an additional 9,839 shares during the period. Kestra Advisory Services LLC acquired a new position in AB Corporate Bond ETF during the 4th quarter valued at approximately $34,000. Finally, Wealth Enhancement Advisory Services LLC boosted its position in AB Corporate Bond ETF by 32.5% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 157,702 shares of the specialty pharmaceutical company’s stock valued at $5,634,000 after purchasing an additional 38,685 shares during the period. Institutional investors and hedge funds own 64.16% of the company’s stock.

AB Corporate Bond ETF Stock Performance

NASDAQ:EYEG traded down $0.18 during midday trading on Friday, reaching $35.01. 13 shares of the company traded hands, compared to its average volume of 193. AB Corporate Bond ETF has a twelve month low of $34.59 and a twelve month high of $36.63. The firm has a market capitalization of $28.01 million, a price-to-earnings ratio of -20.84 and a beta of 0.18. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.07 and a quick ratio of 3.07. The company has a fifty day moving average price of $35.30 and a 200 day moving average price of $35.72.

AB Corporate Bond ETF Dividend Announcement

The business also recently disclosed a monthly dividend, which was paid on Wednesday, May 6th. Investors of record on Friday, May 1st were given a dividend of $0.1404 per share. The ex-dividend date was Friday, May 1st. This represents a c) dividend on an annualized basis and a yield of 4.8%. AB Corporate Bond ETF’s payout ratio is currently -103.57%.

About AB Corporate Bond ETF

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.